Morpholino pyrimidines and their use in therapy

摘要

The disclosure relates to pyrimidinyl compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein the variables are as defined in the specification. The disclosure also provides processes for their preparation, pharmaceutical compositions containing them and their use in therapy. These compounds are suitable for the treatment of cancer or for the prevention or treatment of those tumours which are sensitive to inhibition of ATR kinase.